Discover key considerations and challenges in implementing N-1 perfusion technology, as well as the impact of continuous technology on tech transfer and process scale-up.

This presentation addresses keys to outsourced drug production, including the importance of seeking the right partnerships to help overcome the challenges associated with secure commercial product supply.

Where reducing time to market can determine a key factor for a successful business, selecting the right pathway from the start is critical to prevent any future risks. Learn about what to consider in selecting the best cell line to accelerate speed to market.

Unprecedented times provide opportunities to advance innovative technology, establish a robust business contingency plan, and reduce lead time to drug delivery.

With ongoing development efforts seeing infinite possibilities for cancers, autoimmune diseases, and genetic diseases, how should the industry apply this early victory into successful mRNA-based therapeutics and vaccines?

This webinar describes the acceleration of tech transfer to enable kickoff to vial thaw for antibody manufacture within three months for a clinical program and five months for  process qualification.

How can you get to IND faster through an accelerated and high-performance proprietary cell line? Learn about a 3-month cell line development timeline and a high-quality cell line with outstanding productivity.

Here we present process development and characterization strategies required to support commercial scale manufacture of antibody therapeutics. 

We are determined and resolute in our purpose: to be always dynamic, always responsible, and always innovative. It's in our DNA and it’s a part of who we are.

Samsung Biologics proudly presents the official launch of their proprietary cell line, S-CHOice, a high-performing technology to start your successful therapeutics development journey. We can now offer our clients even more promising options in bringing their molecule faster and better to the market with world-class client satisfaction.

Samsung Biologics’ vision is to enrich human life with technology and innovation. By continuously innovating our people, process, and portfolio, we will fulfill our mission to become the most trusted partner to our clients working together to achieve "Better Life" for humanity through biomedicines.

Using our expertise and innovation, we can help you maximize your opportunity to get your molecule to market and patients, faster and better.